WebMar 28, 2024 · CyPath ® Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Services. OncoSelect Therapeutics, LLC, a subsidiary of bioAffinity … WebCYPATH-RB has specialized in the co-development and clinical validation of artificial intelligence tools in pathology, wishing to become a major player in digital pathology and …

CYPATH Company Profile - Dun & Bradstreet

WebMar 28, 2024 · In a recent clinical trial, CyPath® Lung showed 92% sensitivity and 87% specificity in high-risk patients who had nodules smaller than 20 millimeters or no nodules in the lung, with an area under ... WebJul 7, 2024 · CYPATH's laboratory aims to scan two million slides per year. So far, an estimated less than five percent of labs across Europe have enhanced their pathology … howlett logistics

bioAffinity Technologies Announces Publication of Peer-Reviewed …

WebOct 12, 2024 · Oct 12, 2024 Press Releases. OCTOBER 10, 2024. (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued development and commercial sale of CyPath® Lung as a Laboratory Developed Test (LDT) for the … WebAug 12, 2024 · CyPath™ Lung for Physician’s Use. Home / CyPath™ Lung for Physician’s Use. CyPath™ Lung for Physician’s Use. CyPath™ Lung Physician Portal. A Spirit of Excellence. Our passion is to selflessly serve our clients and their patients by providing excellent pathology services with Integrity and Ethical Behavior as our guiding values. WebAug 11, 2024 · Stakeholders expect there will be plenty of demand for the CyPath Lung test. “Lung cancer is the leading cancer killer,” said Dr. Roby Joyce , president of Precision Pathology. howlett michael